Skip to main content
Log in

Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872

  • Short Communication
  • ACNU, Non-Small-Cell Lung Cancer
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

A total of 62 patients with metastatic or locally advanced non-small-cell lung cancer were entered in a phase II study of ACNU. Initially, the drug was given i. v. at a dose of 100 mg/m2 every 6 weeks, but due to observed haematological side effects in chemotherapy-pretreated patients, the dose was lowered in this group to 75 mg/m2. We observed one complete response in a subject exhibiting multiple lung metastases and a partial response in two patients, one showing brain metastases and one who experienced local disease recurrence. The toxicity of ACNU mainly consisted of bone marrow suppression especially thrombocytopenia, with one toxic death occurring due to intracerebral haemorrhage. We concluded that at this dose and on this schedule, ACNU has limited activity in non-small-cell lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Arakawa M, Shimizu F, Okada N (1974) Effect of 1-(4-amino-2-methylpyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosurea hydrochloride on leukemia L-1210. Gann 65: 191

    Google Scholar 

  2. Cooperative Study Group (1976) Phase I study of ACNU. Jpn J Clin Oncol 6: 55–62

    Google Scholar 

  3. Saijo N, Niitani H (1980) Experimental and clinical effect of ACNU in Japan, with emphasis on small-cell carcinoma of the lung. Cancer Chemother Pharmacol 4: 165–171

    Google Scholar 

  4. Sasaki Y, Saijo N, Shimuzu E (1985) Phase II study of ACNU for non-small-cell lung cancer. Eur J Cancer Clin Oncol 21: 1557–1559

    Google Scholar 

  5. Shimizu F, Arakawa M (1978) Antitumor activity of ACNU in a variety of experimental tumors. Gann 69: 545–548

    Google Scholar 

  6. Sorensen JB, Clerici M, Hansen HH (1988) Review. Single-agent chemotherapy for advanced adenocarcinoma of the lung. Cancer Chemother Pharmacol 21: 89–102

    Google Scholar 

  7. WHO (1979) Handbook for reporting results of cancer treatment. Offset Publication 45. WHO, Geneva

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Planting, A.S.T., Ardizzoni, A., Estapé, J. et al. Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872. Cancer Chemother. Pharmacol. 28, 145–146 (1991). https://doi.org/10.1007/BF00689706

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689706

Keywords

Navigation